Commonly used to treat bacterial infections ranging from pink eye to pneumonia, the antibiotic azithromycin emerged as an early candidate for treating bacterial co-infections tied to SARS-CoV-2.  But a recent clinical trial of the common antibiotic found that the drug is not an effective therapy for hospitalized COVID-19 patients.  The U.K.-based RECOVERY trial had previously…